Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Debette S, Visvikis-Siest S, Chen MH, Ndiaye NC, Song C, Destefano A, Safa R, Azimi Nezhad M, Sawyer D, Marteau JB, Xanthakis V, Siest G, Sullivan L, Pfister M, Smith H, Choi SH, Lamont J, Lind L, Yang Q, Fitzgerald P, Ingelsson E, Vasan RS, Seshadri S.

Circ Res. 2011 Aug 19;109(5):554-63. doi: 10.1161/CIRCRESAHA.111.243790. Epub 2011 Jul 14.

2.

Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints.

Watfa G, Marteau JB, Rossignol P, Kearney-Schwartz A, Fay R, Bracard S, Felblinger J, Boivin JM, Lacolley P, Visvikis-Siest S, Benetos A, Zannad F.

Dement Geriatr Cogn Disord. 2010;30(5):440-8. doi: 10.1159/000321120. Epub 2010 Nov 25.

PMID:
21109737
3.

Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.

Marteau JB, Rigaud O, Brugat T, Gault N, Vallat L, Kruhoffer M, Orntoft TF, Nguyen-Khac F, Chevillard S, Merle-Beral H, Delic J.

BMC Med Genomics. 2010 Nov 10;3:53. doi: 10.1186/1755-8794-3-53.

4.

Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences.

Herbeth B, Samara A, Ndiaye C, Marteau JB, Berrahmoune H, Siest G, Visvikis-Siest S.

Clin Chim Acta. 2010 Jun 3;411(11-12):833-9. doi: 10.1016/j.cca.2010.02.070. Epub 2010 Feb 25.

PMID:
20219453
5.

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Zaiou M, Benachour H, Marteau JB, Visvikis-Siest S, Siest G.

Curr Pharm Des. 2009;15(27):3193-206. Review.

PMID:
19754391
6.

Personalized therapy and pharmacogenomics: future perspective.

Siest G, Marteau JB, Visvikis-Siest S.

Pharmacogenomics. 2009 Jun;10(6):927-30. doi: 10.2217/pgs.09.45. No abstract available.

7.

Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical steps.

Siest G, Jeannesson E, Marteau JB, Samara A, Pfister M, Visvikis-Siest S.

Curr Drug Metab. 2009 May;10(4):410-9. Review.

PMID:
19519347
8.

Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study.

Berrahmoune H, Herbeth B, Samara A, Marteau JB, Siest G, Visvikis-Siest S.

Int J Obes (Lond). 2008 Aug;32(8):1279-88. doi: 10.1038/ijo.2008.94. Epub 2008 Jul 8.

PMID:
18607382
9.

P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study.

Marteau JB, Lambert D, Herbeth B, Marie B, Droesch S, Tregouet DA, Visvikis-Siest S.

J Thromb Haemost. 2008 Jun;6(6):920-7. doi: 10.1111/j.1538-7836.2008.02952.x. Epub 2008 Mar 21.

PMID:
18363816
10.

Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects.

Siest G, Jeannesson E, Marteau JB, Samara A, Marie B, Pfister M, Visvikis-Siest S.

Drug Metab Dispos. 2008 Jan;36(1):182-9. Epub 2007 Oct 16.

11.

Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.

Gary-Gouy H, Sainz-Perez A, Marteau JB, Marfaing-Koka A, Delic J, Merle-Beral H, Galanaud P, Dalloul A.

J Immunol. 2007 Oct 1;179(7):4335-44.

12.

Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems.

Visvikis-Siest S, Marteau JB, Samara A, Berrahmoune H, Marie B, Pfister M.

Clin Chem Lab Med. 2007;45(9):1154-68.

PMID:
17663631
13.

[Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Ann Pharm Fr. 2007 May;65(3):203-10. Review. French.

PMID:
17489077
14.

Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort.

Gambier N, Marteau JB, Batt AM, Marie B, Thompson A, Siest G, Foernzler D, Visvikis-Siest S.

J Hypertens. 2006 Nov;24(11):2199-205.

PMID:
17053541
15.

Genetic variants predisposing to cardiovascular disease.

Visvikis-Siest S, Marteau JB.

Curr Opin Lipidol. 2006 Apr;17(2):139-51. Review.

PMID:
16531750
16.

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Eur J Pharmacol. 2005 Dec 19;527(1-3):1-22. Epub 2005 Nov 28. Review.

PMID:
16316654
17.

E-selectin genotypes and risk of type 2 diabetes in women: genetic and environmental contributions to serum soluble E-selectin concentrations.

Marteau JB, Herbeth B, Lambert D, Visvikis-Siest S.

Obes Res. 2005 Oct;13(10):1845-7. No abstract available.

PMID:
16286535
18.

Genetic determinants of blood pressure regulation.

Marteau JB, Zaiou M, Siest G, Visvikis-Siest S.

J Hypertens. 2005 Dec;23(12):2127-43. Review.

PMID:
16269952
19.

Collection and storage of human blood cells for mRNA expression profiling: a 15-month stability study.

Marteau JB, Mohr S, Pfister M, Visvikis-Siest S.

Clin Chem. 2005 Jul;51(7):1250-2. No abstract available.

20.

Pharmacogenomics and drug response in cardiovascular disorders.

Siest G, Jeannesson E, Berrahmoune H, Maumus S, Marteau JB, Mohr S, Visvikis S.

Pharmacogenomics. 2004 Oct;5(7):779-802. Review.

PMID:
15469403
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk